



PLECT or PPLECT? Granulomatous pyoderma gangrenosum in the 





is a diagnosis of exclusion and should be included in the differential diagnoses of the  verrucous syndrome. We report  a 
granulomatous variant affecting the face. 
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Pyoderma	gangrenosum	(PG)	is	an	uncommon	entity	with	
a	diverse	clinical	spectrum	and	nonspecific	histopathology.	Aware-




We report a 72-year-old male patient who sought care for 




The	patient	was	a	 smoker	 (more	 than	30	pack-years	 ),	previously	
healthy,	and	denied	the	use	of	medications.









for	 detection	 and	 culturing	 of	 fungi,	 bacteria,	 and	 mycobacteria	
were negative. Direct inspection for Leishmania sp. (Giemsa) on the 
lesion was negative; the Mantoux	(PPD)	test	was	nonreactive.
After	 excluding	 infectious	 and	 neoplastic	 causes,	 the	 hy-
pothesis of granulomatous PG variant was discussed and estab-
lished	 as	 the	 principal	 possibility.	 Prednisone	 (1mg/kg/day),	 in	
combination	 with	 trimethoprim/sulfamethoxazole	 (TMP/SMX;	
800mg	+	160mg),	was	initiated,	with	regression	of	the	lesions	in	the	
first	 month	 of	 treatment.	 Prednisone	 was	 gradually	 tapered	 and	
dapsone		(50mg/day)	substituted	for	TMP/SMX.	Currently,	the	pa-
tient	 remains	asymptomatic	on	dapsone	 (100mg/day)	alone	 .	The	
investigation for underlying diseases possibly associated with PG 
showed no abnormalities.




diagnosis is based on clinicopathological correlation and on the ex-
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mediators and genetic predisposition. It has been described in as-
sociation	with	underlying	systemic	diseases	in	50%	of	cases,	most	
commonly	inflammatory	bowel	disease,	rheumatological	or	hema-
tological	 conditions	 (monoclonal	 gammopathy,	 myelodysplasia,	
acute	myeloid	leukemia).4 
Although	 the	 classic	 morphology	 comprises	 	 nodules	 or	
papules	 that	 evolve	 into	 rapidly	 progressive,	 painful	 ulcers	with	
violaceous	 borders	 and	 a	 purulent	 base,	 there	 are	 many	 clinical	
variants	such	as	 	ulcerative,	bullous,	pustular	and	granulomatous	
subtypes.5	Granulomatous	PG	can	exhibit	verrucous	characteristics,	






are not pathognomonic.5 
The	diagnosis	 is	often	challenging	and	delayed,	 requiring	
clinical and pathological correlation; hence the importance of famil-
iarity with the differential diagnoses and morphological aspects. It 
should be noted that PG may be included as a differential diagnosis 
of	the	verrucous	syndrome,	classically	recognized	by	the	mnemon-
ic	 term	 “PLECT”	 (paracoccidioidomycosis,	 leishmaniasis,	 sporo-
trichosis,	chromomycosis,	tuberculosis).	Histoplasmosis	should	also	
be considered. 
Negative screening investigation for systemic  disease 
prompted us to consider the idiopathic nature of PG in our patient. 
Facial	involvement	was	striking	and	the		excellent	response	to	both	
steroid  and sulfonamide should be highlighted. Given the distinct 






The most effective treatment for PG is systemic corticother-
apy,	which	 can	be	 administered	 through	pulse	 therapy	 for	 	more	
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FIgure 1: Before and after treatment. 
Left:	 extensive	 verrucous	 plaque	 in	
the	 right	 temporomalar	 region,	with	
erythematous	and	infiltrated	borders	
and	scaly,	crusted	central	ulcerations.	
Right: appearance after the estab-
lished therapy
FIgure 2: Histopathology:	 chronic	 granulomatous	 inflammatory	
process	(Hematoxylin	&	eosin,	x200)
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